37th National Medicinal Chemistry Symposium

American Chemical Society
Division of Medicinal Chemistry

 New York City, NY, United States    June 28-July 1, 2020

Session Topics & Chairs

The Program of the 37th NMCS will include the following Sessions:

  • Integrating Novel Chemical Modalities in Hit-to-lead: a New Paradigm for Early Drug Discovery
    Chair: Maria-Jesus Blanco (SAGE Therapeutics)

  • New Directions in Targeting DNA Damage Repair (DDR)
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Srinivasa Karra (Alkermes, Inc.)

  • Hot Targets from NYC Academic and Biotech Scene
    Chairs: Robert DeVita (Icahn School of Medicine at Mt Sinai) and Amjad Ali (Merck & Co. Inc.)

  • Targeting Autophagy for Cancer, Neurodegeneration, or Autoimmune Disease
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Hongjun Zhang (Merck & Co. Inc.)

  • “If At First You Don’t Succeed, Try, Try, Try Again”: How Clinical Failures Propelled Next Generation Candidates
    Chair: Matthew Volgraf (Genentech Inc.)

  • Lessons from Drug Hunters across Academia, NPOs and the Pharmaceutical Industry
    Chair: Phil Kym (AbbVie)

In addition, the Program will also feature the MEDI Award Session.